Advertisement
SAN FRANCISCO, Nov. 14, 2018 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the addition of Dr. Jill Carnahan, MD, founder and medical director of Flatiron Functional Medicine to its Medical Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Carnahan will bring to uBiome extensive experience in treating the root causes of disease, conscientiously taking into account nutritional, bacterial, and biochemical imbalances. The appointment will help uBiome continue its advancement in human microbiome research.
"Functional medicine practitioners have consistently been some of the earliest adopters and biggest champions of microbiome analysis as part of clinical care," Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. "Dr. Carnahan is an accomplished functional medicine expert, and we are thrilled to bring her expertise to uBiome's Medical Advisory Board."
Dr. Carnahan has dedicated her career to patient care and educating healthcare providers about the value of a functional medicine practice. She currently works at Flatiron Functional Medicine. Previously, she founded the Methodist Center for Integrative Medicine in 2009. She received her medical degree from Loyola University Stritch School of Medicine in Chicago and completed her residency at the University of Illinois Program in Family Medicine at Methodist Medical Center.
About joining uBiome's Medical Advisory Board, Dr. Carnahan said, "I am excited to join the uBiome team as a functional medicine expert and long-term advocate for increasing microbial diversity and enhancing health outcomes through optimizing gut function."
In addition to Dr. Carnahan, the uBiome Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company's Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children's Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
_____ About uBiome Founded in 2012, uBiome is the leader in microbial genomics. The Company's mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.
uBiome's commercial products include SmartGut™, the world's first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome's platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company's Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.
SOURCE uBiome
Advertisement
"Functional medicine practitioners have consistently been some of the earliest adopters and biggest champions of microbiome analysis as part of clinical care," Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. "Dr. Carnahan is an accomplished functional medicine expert, and we are thrilled to bring her expertise to uBiome's Medical Advisory Board."
Dr. Carnahan has dedicated her career to patient care and educating healthcare providers about the value of a functional medicine practice. She currently works at Flatiron Functional Medicine. Previously, she founded the Methodist Center for Integrative Medicine in 2009. She received her medical degree from Loyola University Stritch School of Medicine in Chicago and completed her residency at the University of Illinois Program in Family Medicine at Methodist Medical Center.
About joining uBiome's Medical Advisory Board, Dr. Carnahan said, "I am excited to join the uBiome team as a functional medicine expert and long-term advocate for increasing microbial diversity and enhancing health outcomes through optimizing gut function."
In addition to Dr. Carnahan, the uBiome Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company's Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children's Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
_____ About uBiome Founded in 2012, uBiome is the leader in microbial genomics. The Company's mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.
uBiome's commercial products include SmartGut™, the world's first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome's platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company's Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.
SOURCE uBiome
